Time to reality check the promises of machine learning-powered precision medicine.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
12 2020
Historique:
received: 24 06 2020
revised: 29 07 2020
accepted: 07 08 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 28 1 2021
Statut: ppublish

Résumé

Machine learning methods, combined with large electronic health databases, could enable a personalised approach to medicine through improved diagnosis and prediction of individual responses to therapies. If successful, this strategy would represent a revolution in clinical research and practice. However, although the vision of individually tailored medicine is alluring, there is a need to distinguish genuine potential from hype. We argue that the goal of personalised medical care faces serious challenges, many of which cannot be addressed through algorithmic complexity, and call for collaboration between traditional methodologists and experts in medical machine learning to avoid extensive research waste.

Identifiants

pubmed: 33328030
pii: S2589-7500(20)30200-4
doi: 10.1016/S2589-7500(20)30200-4
pmc: PMC9060421
mid: NIHMS1702565
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e677-e680

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : K01 HL141771
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

J Pers Med. 2018 May 07;8(2):
pubmed: 29735910
PLoS Med. 2018 Nov 27;15(11):e1002699
pubmed: 30481176
BMJ. 2018 Dec 10;363:k4245
pubmed: 30530757
NPJ Digit Med. 2019 Mar 19;2:16
pubmed: 31304364
Reprod Biomed Online. 2019 Jun;38(6):853-856
pubmed: 31023611
Ups J Med Sci. 2019 Jan;124(1):51-58
pubmed: 30265168
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
PLoS Med. 2018 Nov 20;15(11):e1002686
pubmed: 30457988
BMC Med Res Methodol. 2019 Jul 24;19(1):162
pubmed: 31340753
N Engl J Med. 2006 Aug 3;355(5):467-77
pubmed: 16885550
BMJ. 2015 Nov 04;351:h5651
pubmed: 26537915
IEEE Rev Biomed Eng. 2019;12:194-208
pubmed: 30106692
BMJ. 2020 Mar 25;368:m689
pubmed: 32213531
BMJ. 2020 Mar 20;368:l6927
pubmed: 32198138
Nat Med. 2019 Jan;25(1):65-69
pubmed: 30617320
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
Br J Cancer. 2011 Mar 29;104(7):1057-8
pubmed: 21448174
Lancet Digit Health. 2019 Oct;1(6):e271-e297
pubmed: 33323251
BMJ. 2016 May 16;353:i2416
pubmed: 27184143
J Clin Epidemiol. 2019 Oct;114:72-83
pubmed: 31195109
JAMA. 2020 Feb 11;323(6):509-510
pubmed: 31845963
Stat Med. 2016 Mar 30;35(7):966-77
pubmed: 26415869
JAMA. 2018 Apr 24;319(16):1725-1726
pubmed: 29710156
NPJ Digit Med. 2018 Aug 28;1:39
pubmed: 31304320
Lancet Public Health. 2019 May;4(5):e209
pubmed: 31054633
Int J Epidemiol. 2021 Jan 23;49(6):2074-2082
pubmed: 32380551

Auteurs

Jack Wilkinson (J)

Centre for Biostatistics, Manchester Academic Health Science Centre, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK. Electronic address: jack.wilkinson@manchester.ac.uk.

Kellyn F Arnold (KF)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of Medicine and Health, University of Leeds, Leeds, UK.

Eleanor J Murray (EJ)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Maarten van Smeden (M)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.

Kareem Carr (K)

Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA.

Rachel Sippy (R)

Institute for Global Health and Translational Science, SUNY Upstate Medical University, Syracuse, NY, USA; Department of Geography, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.

Marc de Kamps (M)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; School of Computing, University of Leeds, Leeds, UK.

Andrew Beam (A)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Stefan Konigorski (S)

Digital Health & Machine Learning Research Group, Hasso Plattner Institut for Digital Engineering, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Christoph Lippert (C)

Digital Health & Machine Learning Research Group, Hasso Plattner Institut for Digital Engineering, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Mark S Gilthorpe (MS)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of Medicine and Health, University of Leeds, Leeds, UK; Alan Turing Institute, London, UK.

Peter W G Tennant (PWG)

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; Faculty of Medicine and Health, University of Leeds, Leeds, UK; Alan Turing Institute, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH